drugset / Trial / NCT03709121
A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber
RandomizedCrossoverQuadruple-blindTreatment
Summary
An Exploratory Clinical Trial Evaluating Reproxalap Ophthalmic Solutions (0.25% and 0.5%) in Subjects with Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber (EEC)
Timeline
- Start
- 2018-10-02
- Primary completion
- 2019-03-20
- Completion
- 2019-03-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Reproxalap | Other / unclassified | 0.25 % | — |
| Subject | Reproxalap | Other / unclassified | 0.5 % | — |